A Programmable Calcification Nanoplatform for Loco‐Regional Calcification‐Immune Hepatocellular Carcinoma Therapy
Advanced Science · 2026
DOI: 10.1002/advs.76642 ↗At a glance
Journal article in Advanced Science, 2026. Written by Long Liu and 11 co-authors. Institution: Shaanxi Province Center for Regenerative Medicine and Surgery Engineering Research, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an…. Major MEDLINE topics: Calcinosis, Liver Neoplasms, Carcinoma, Hepatocellular, Peroxides. 47 references. The full text is freely available (open access, CC BY 4.0). Funded by: National Natural Science Foundation of China, Sanqin Talent Introduction Plan-Youth Project of Shaanxi Province, Fundamental Research Funds for the Xi'an Jiaotong University.
Abstract (original language)
Inducing tumor calcification is a promising strategy for disrupting cancer progression, yet achieving efficient biomineralization with synergistic antitumor effects remains challenging. Here, a programmable calcification nanoplatform (CaIM) is developed using in situ growth of calcium peroxide (CaO 2 ) on black phosphorus (BP) nanosheets, followed by hyaluronic acid encapsulation. Unlike conventional physical adsorption or co‐precipitation, this in situ growth strategy yields crystalline CaO 2 uniformly anchored on the BP matrix, enabling synchronized release of Ca 2 + , phosphate, and H 2 O 2 in the tumor microenvironment. CaIM induces potent intracellular calcium overload and oxidative stress, triggering mitochondrial dysfunction, cell death, and extensive biological calcification readily visualized via computed tomography (CT). Multi‐omics profiling identifies the mucolipin channel MCOLN2 as a key mediator regulating calcium flux, facilitating stable active biomineralization rather than passive necrotic calcification. This active calcification, coupled with mitochondrial damage, effectively reshapes the immunosuppressive microenvironment by promoting macrophage polarization and T cell infiltration. These findings establish a calcium signaling‐driven paradigm integrating nanocomposite design with synergistic calcium stress, oxidative damage, and immune activation, offering a robust foundation for calcification‐based cancer therapy.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Shaanxi Province Center for Regenerative Medicine and Surgery Engineering Research, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.
- National Local Joint Engineering Research Center for Precision Surgery & Regenerative Medicine, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.
- Department of Hepatobiliary Surgery, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.
- Institute of Regenerative and Reconstructive Medicine, Med-X Institute, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.
- State Key Laboratory of Cellular Stress Biology, Innovation Center for Cell Biology, School of Life Sciences, Xiamen University, Xiamen, China.
- Department of Breast Surgery, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.
ORCID profiles: Long Liu
Funding
- National Natural Science Foundation of China
- Sanqin Talent Introduction Plan-Youth Project of Shaanxi Province
- Fundamental Research Funds for the Xi'an Jiaotong University
- Major State Basic Research Development Program of China
- Fundamental Research Funds for the Central Universities
Cite
APA
Liu, L., Li, P., Lu, Z., Xu, S., Wang, J., Ma, K., Yu, H., Zhou, C., Chen, H., Liu, G., Lyu, Y., & Bai, S. (2026). A Programmable Calcification Nanoplatform for Loco‐Regional Calcification‐Immune Hepatocellular Carcinoma Therapy. Advanced Science. https://doi.org/10.1002/advs.76642
Vancouver
Liu L, Li P, Lu Z, Xu S, Wang J, Ma K, et al. A Programmable Calcification Nanoplatform for Loco‐Regional Calcification‐Immune Hepatocellular Carcinoma Therapy. Advanced Science. 2026. doi:10.1002/advs.76642
BibTeX
@article{Liu2026,
author = {Liu, Long and Li, Peng and Lu, Zhixiang and Xu, Shuqin and Wang, Juanjuan and Ma, Kai and Yu, Haodong and Zhou, Can and Chen, Hu and Liu, Gang and Lyu, Yi and Bai, Shuang},
title = {A Programmable Calcification Nanoplatform for Loco‐Regional Calcification‐Immune Hepatocellular Carcinoma Therapy},
journal = {Advanced Science},
year = {2026},
doi = {10.1002/advs.76642}
}
EUVIMED